This study examines the clinical settings of first-time psychotic spectrum disorder diagnoses in an integrated health system.
Am J Manag Care. 2025;31(11):In Press
Takeaway Points
Psychotic spectrum disorders (PSDs) typically emerge during late adolescence and early adulthood,1 a critical period marked by high rates of health care engagement across various settings, including emergency departments (EDs),2 primary care clinics, and psychiatric services.3,4 Understanding where and how these diagnoses first occur is essential for refining outreach and enhancing mental health care delivery. The transfer of care to a specialty service is often missed or delayed, resulting in lost opportunities for early intervention.5 We examined the clinical settings of first-time PSD diagnoses, shedding light on how an integrated health care system can support earlier and more effective intervention.
This retrospective cohort study used electronic health records of individuals aged 15 to 29 years who received a first-time diagnosis of a PSD between January 1, 2017, and December 31, 2019. PSD diagnoses included schizoaffective disorder (International Classification of Diseases, Tenth Revision, Clinical Modification code F25.X), schizophrenia (F20.X), delusional disorders (F22), schizotypal and brief psychotic disorder (F21, F23), and unspecified or other psychotic disorders (F24, F28, F29) documented from encounters in primary care, inpatient services, EDs, addiction medicine, and psychiatry departments. Analysis of variance and χ2 tests were used to compare patient characteristics across clinical settings. Significance was defined by a P value less than .05.
Among the total cohort of 1726 adult patients with a new diagnosis of PSD, 43.2% were female and the mean (SD) age was 20.9 (4.0) years. The largest share of patients identified as White (38.2%), followed by Latino/Hispanic (25.0%) and Black (19.0%). Nearly half (45.7%) of the initial PSD diagnoses occurred in outpatient psychiatry, whereas 42.0% were made in the ED (Table). In contrast, only 3.8% and 1.7% of initial PSD diagnoses were made in primary care and addiction medicine, respectively (P < .001). More specific diagnoses, such as schizophrenia and schizoaffective disorder, were more often made in outpatient psychiatry; in contrast, both delusional disorders as well as schizotypal and brief psychotic disorder were more frequently diagnosed in the ED (P < .001).
Our results indicate that outpatient psychiatry settings led to more precise diagnoses, likely due to the comprehensive diagnostic evaluations conducted there. More specific diagnoses, in turn, allow for more tailored and detailed treatment plans. We also found that EDs play a significant role in the initial identification of PSDs, emphasizing the need for enhanced diagnostic protocols in these settings. The high proportion of diagnoses made in the ED highlights an opportunity to improve early diagnostic accuracy and ensure that patients receive appropriate follow-up care. Strengthening pathways for patients from the ED to specialty psychiatric care could help reduce these gaps and lead to more accurate diagnoses and timely interventions.
In conclusion, our study emphasizes the importance of the ED as a critical point of contact for the early identification of PSD. The findings support the need for integrated care pathways that connect patients receiving initial diagnoses in acute settings to specialized psychiatric services.
Author Affiliations: Department of Psychiatry, Kaiser Permanente Oakland Medical Center (CH, MEH, IS-S), Oakland, CA; Division of Research, Kaiser Permanente Northern California (AHK-S), Pleasanton, CA; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco (MEH, IS-S), San Francisco, CA.
Source of Funding: The Kaiser Permanente Northern California Office of Graduate Medical Education and the Kaiser Permanente Garfield Memorial Fund.
Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design (CH, MEH, IS-S); acquisition of data (AHK-S, IS-S); analysis and interpretation of data (CH, AHK-S, MEH, IS-S); drafting of the manuscript (CH, AHK-S, MEH, IS-S); critical revision of the manuscript for important intellectual content (CH, AHK-S, MEH, IS-S); statistical analysis (AHK-S); and supervision (IS-S).
Address Correspondence to: Icelini Stavers-Sosa, MD, Kaiser Permanente Oakland Medical Center, 3900 Broadway, Oakland, CA 94611. Email: Icelini.x.stavers-sosa@kp.org.
REFERENCES
1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. doi:10.1001/archpsyc.62.6.593
2. Tempelaar W, Kozloff N, Mallia E, Voineskos A, Kurdyak P. Mental health service use before first diagnosis of a psychotic disorder. JAMA Psychiatry. 2024;81(9):928-935. doi:10.1001/jamapsychiatry.2024.1467
3. Simon GE, Coleman KJ, Yarborough BJH, et al. First presentation with psychotic symptoms in a population-based sample. Psychiatr Serv. 2017;68(5):456-461. doi:10.1176/appi.ps.201600257
4. Myran DT, Harrison LD, Pugliese M, et al. Transition to schizophrenia spectrum disorder following emergency department visits due to substance use with and without psychosis. JAMA Psychiatry. 2023;80(11):1169-1174. doi:10.1001/jamapsychiatry.2023.3582
5. Esque J, Rasmussen A, Spada M, Gopalan P, Sarpal D. First-episode psychosis and the role of the psychiatric consultant. J Acad Consult Liaison Psychiatry. 2022;63(1):32-35. doi:10.1016/j.jaclp.2021.07.003

Managed Care Reflections: A Q&A With Laurie C. Zephyrin, MD, MPH, MBA
November 12th 2025To mark the 30th anniversary of The American Journal of Managed Care, each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The November issue features a conversation with Laurie C. Zephyrin, MD, MPH, MBA, senior vice president for achieving equitable outcomes at the Commonwealth Fund. This interview has been edited for length and clarity.
Read More